back to company universe
Healthcare

Nomic Bio

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in

sources
1
Evidence entries preserved.
affiliations
1
Y Combinator
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #4220

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in

source
generated read
High Signal interpretation

Nomic Bio is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
nELISAELISAnext-gen immunoassay platformcore technologyHTS groups
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Nomic Bio

Healthcare · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Talus Bio

match 64

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

shared extracted concept terms: next, gen; shared product terms: protein, next, gen, drug; same category: Healthcare; shared affiliation: Y Combinator

Maritime Fusion

match 59

Maritime Fusion is building fusion reactors for ships and off grid energy markets. En route on this endeavor we’re commercializing High Temperature Superconducting (HTS) cable technology for power distribution while advancing the physics basis of our HTS tokamak to decarbonize global shipping. Breakeven fusion is coming soon, but the first-of-a-kind (FOAK) reactors will be costly, high maintenance, and have low capacity factors, leading to 5–10x higher electricity cost on the grid. Maritime Fusi

shared extracted concept terms: hts; shared product terms: re, high, hts, 10x; shared affiliation: Y Combinator

Arpeggio Bio

match 57

Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.

shared product terms: develop, drug, high, throughput; shared affiliation: Y Combinator

Remesh

match 54

A next-gen platform for engaging and understanding a group of people

shared extracted concept terms: next, gen, group; shared product terms: next, gen, group

Dating Ring

match 49

We're a Y Combinator W'14 class. We use matchmakers to set up group dates. What Uber has done for transportation - we're doing for dating. Members can book high quality dates on their schedule with the click of a button. Dating Ring is live in NYC and SF and will be launching next in Boston and LA.

shared product terms: re, group, what, doing; shared affiliation: Y Combinator

Correlia Biosystems

match 49

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

shared product terms: develop, protein, profile, enabl; shared affiliation: Y Combinator